A study listed on ClinicalTrials.gov.

Recruiting now. Registry record last updated September 10, 2025.

Who can join: Adults 18+, BMI 25+.
What you take: Check ClinicalTrials.gov for this trial's study groups and what each group receives.
How long it lasts: The study runs about 17 months.
What you get: Costs vary by study. Ask the study team what this one covers, including the study medicine, visits and travel, before you sign the consent form.

This one may not fit you. We check your age, where you live, and the rules each study sets, then show the clinical trials that do.

Check my fit →

Phase Not ApplicableSponsor Penn State UniversityDrug investigational drugClass OtherSites 1 USEnrollment target 25

What this study is for

Primary condition: Weight Loss. Also studied in: Food Selection.

Full scientific study title: Identifying Changes in Food Behaviors Associated With Beginning GLP-1 Medication.

Who can join

Age18 and upSexAnyBMI25 or higher

Adults 18+, BMI 25+. A site coordinator confirms whether you qualify during a free screening visit. The exact medical requirements are below.

Full medical eligibility (for you and your doctor)verbatim from the registry

This is the exact wording from ClinicalTrials.gov, including clinical measures (lab values, imaging scores). Bring it to your doctor if any of it is unclear.

Key inclusion criteria

Adults (18+) with overweight or obesity (BMI \>25 kg/m2)
Not currently taking an incretin-based medication at baseline
Recently (within two weeks) prescribed a GLP-1, can be included if they have a obesity-related co-occurring condition (diabetes, hypertension, cardiovascular disease, dyslipidemia)
Have had no prior diagnosis of cognitive or physical disability, dyslexia, or epilepsy.
Fluent in English

Key exclusion criteria

Adults (18+) without overweight or obesity
\<18 years of age at time of testing
Adults not taking a GLP-1 Medication
Adults taking a compound GLP-1
Adults on GLP-1 medication for longer than 2 weeks at baseline

Where this trial is enrolling

This trial has 1 sites across 1 state. Contact a site coordinator directly to start screening.

Pennsylvania1 site

Health, Ingestive Behavior, and Technology Laboratory of Pennsylvania State University
State College, Pennsylvania
Christina M Blackmon425-499-8049cmb8633@psu.edu

Follow this trial

We email you if NCT06843512 changes status, adds new sites in your state, or if a similar trial opens for the same condition.

Timeline

Started enrolling: July 15, 2025. Expected completion: December 2026. Last updated on ClinicalTrials.gov: September 10, 2025.

Official source

Every Monday we check this trial against ClinicalTrials.gov, the federal registry for clinical research. Last checked September 4, 2026. Confirm the current status there before you contact a site:

View on ClinicalTrials.gov →

Back to the full directory → or take the matching quiz if you want clinical trials filtered to your conditions and location.

John Samaras, Founder and EditorI started GLP Chart after overpaying for a GLP-1 myself. Based in Austin, Texas.
About this site LinkedIn Contact

Why you can trust GLP Chart. Same scoring framework applied to every program. No paid placements. We never remove unfavorable information at an advertiser's request. Pricing is pulled from each program's public-facing page every Monday.